A b s t r a c t
Lymphoid neoplasms comprise a group of closely related yet heterogeneous diseases. Categorizing the various lymphoid neoplasms has proven to be enormously challenging, and has resulted in the evolution of numerous clinical and pathologic classification schemes over the past 50 years. [1] [2] [3] Recent revolutionary advances in immunology, genetics, and molecular biology have resulted in extensive changes in the classifications of these tumors, culminating in the Revised EuropeanAmerican classification (1994) 4 and its successor, the World Health Organization (WHO) classification (2001 and 2008). 5, 6 Together, lymphoid neoplasms comprise the sixth most common group of malignancies worldwide in men and women, 7 but there are marked geographic variations, with the highest rates observed in North America and Australia, followed by Europe, and lower rates throughout Asia. 8, 9 Ethnic and regional differences are seen in the distribution of subtypes. For example, Asian populations have higher proportions of mature T/NK-cell neoplasms and extranodal marginal zone B-cell lymphoma and lower proportions of follicular lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma than Western populations. 5, 6, [10] [11] [12] [13] [14] [15] [16] [17] The strongest known risk factor for lymphoid neoplasm is severe immunodeficiency, but the causes of most lymphomas remain unknown. 10, 16, 18 Thus the comparison of incidence rates and patterns of specific subtypes may provide critical clues for future etiologic investigations.
To date, only a few small descriptive analyses have focused on the subtype, age, sex, and lesion of primary and resected biopsy specimens and their distribution patterns in China for all of the lymphoid neoplasm subtypes defined by the WHO classification. 11, [19] [20] [21] To describe the epidemiologic features of the entire spectrum of lymphoid neoplasms in To determine the exact distribution, cases that were referred only for consultation were excluded. The diagnosis was made using a comprehensive diagnostic system that included morphology, immunohistochemistry, in situ hybridization for Epstein Barr virus-encoded RNA, polymerase chain reaction-based techniques for the analysis of clonality, and fluorescence in situ hybridization. Patients suspected of having a lymphoid neoplasm based on morphologic findings, with ambiguous immunostaining results or insufficient tissue sample for full characterization, were excluded. A total of 4,638 lymphoid neoplasm patients were enrolled in the study.
Materials and Methods
When patients had 2 or more tissue samples collected at different times, the diagnosis was based on the first sample. All cases were histologically reconfirmed and grouped into subtypes according to the 2001 and 2008 WHO classification system. When applicable, the International Lymphoma Epidemiology Consortium (InterLymph) guideline 15 was used. Clinical information obtained from medical records for the calendar year of the diagnosis included patient sex and age and the site of tissue sampling.
Differences were assessed using independent samples t test. P values of less than .05 were considered statistically significant. All statistical analyses were performed using SPSS software for Windows, version 17.0 (SPSS, Chicago, IL). The ethics committee of the Peking Union Medical College Hospital approved this study.
Results

Subtype Distribution of Lymphoid Neoplasms
Of the 4,638 patients diagnosed with lymphoid neoplasms from 2004 to 2008, 2,983 (64.3%) had mature B-cell neoplasms, 1,082 (23.3%) had mature T/NK-cell neoplasms, 399 (8.6%) had Hodgkin lymphomas, and 174 (3.8%) had precursor lymphoid neoplasms ❚Table 1❚. The most common subtype was diffuse large B-cell lymphoma (36.2%), followed by extranodal NK/T-cell lymphoma, nasal type (11.0%); classic Hodgkin lymphoma (8.4%); extranodal marginal zone B-cell lymphoma (7.7%); plasmacytic neoplasm (5.0%); and peripheral T-cell lymphoma, not otherwise specified (NOS; 3.9%). There were 111 (2.4%) anaplastic large cell lymphomas, including 68 anaplastic lymphoma kinase (ALK)+ cases and 43 ALK-cases.
Of the 399 patients with Hodgkin lymphoma, 8 (2.8%) had nodular lymphocyte predominance type and 391 (97.2%) had classic Hodgkin lymphoma, with mixed cellularity Hodgkin lymphoma being the most common subtype (211 patients, 52.9%).
Age and Sex Distribution
Lymphoid neoplasm subtypes were seen more often in male subjects than in female subjects. The male-female (M/F) ratio was 1.7 for all lymphoid neoplasms, 1.7 for non-Hodgkin lymphomas, 2.2 for precursor lymphoid neoplasms, 1.6 for mature B-cell neoplasms, and 2.2 for mature T/NK-cell neoplasms. The highest male predominance was observed in patients with non-Hodgkin lymphoma with Burkitt lymphoma (5.7), extranodal NK/T-cell lymphoma, nasal type (2.6), mantle cell lymphoma (2.5), and plasmacytic neoplasm NOS (2.5). In contrast, female predominance was seen in splenic B-cell marginal zone lymphoma (0.5). In Hodgkin lymphoma, the overall M/F ratio was 1.8; male predominance was seen for lymphocyte-rich Hodgkin lymphoma (2.8) and mixed cellularity Hodgkin lymphoma (2.5).
Most mature lymphoid neoplasms were diseases of adults. The mean age was 32.9 years for Hodgkin lymphomas, 54.4 years for mature B-cell neoplasms, and 43.7 years for mature T/NK-cell neoplasms. Patients with mature T/NKcell neoplasms were significantly younger than patients with mature B-cell neoplasms (mean age, 43.7 vs 54.4 years, P < .001), and patients with Hodgkin lymphomas were significantly younger than those with mature non-Hodgkin lymphomas (mean age, 32.9 vs 51.6 years; P < .001).
Among the 318 pediatric lymphomas, mixed cellularity Hodgkin lymphoma was the most common (57 patients, 17.9%), followed by T-lymphoblastic leukemia/lymphoma (50 patients, 15.7%), diffuse large B-cell lymphoma (34 patients, 10.7%), and extranodal NK/T-cell lymphoma, nasal type (28 patients, 8.8%) ❚Table 2❚.
The mean ages for Burkitt lymphoma (25.6 years) and mediastinal (thymic) large B-cell lymphoma (34.9 years) were less than those for major mature B-cell neoplasms, including diffuse large B-cell lymphoma (mean age, 54.5 years), plasmacytic neoplasm (mean age, 55.4 years), extranodal marginal zone B-cell lymphoma (mean age, 55.6 years), follicular lymphoma (mean age, 56.3 years), and chronic lymphocytic leukemia/small lymphocytic lymphoma (mean age, 59.6 years; P < .001).
For mature T/NK-cell neoplasms, patients with anaplastic large cell lymphoma (mean age, 33.7 years) were significantly younger than patients with extranodal NK/T cell lymphoma, nasal type (mean age, 43.1 years, P = .005), and peripheral T-cell lymphoma, NOS (mean age, 48.5 years, P < .001). Furthermore, patients with angioimmunoblastic T-cell lymphoma (mean age, 62.9 years) were significantly older than patients with extranodal NK/T-cell lymphoma, nasal type, and peripheral T-cell lymphoma, NOS (P < .001).
Distribution of Lesions With Primary and Resected Biopsies
The anatomic sites of sampling in the primary diagnosis of lymphoid neoplasms are shown in ❚Table 3❚. The common sites of diagnosis were lymph nodes (36.6%), gastrointestinal tract (15.5%), nasal cavity/sinus (8.3%), and Waldeyer ring (7.3%). Diffuse large B-cell lymphoma was the most common type (32.2%) for lymph node lesions, followed by mixed cellularity Hodgkin lymphoma (11.1%), chronic lymphocytic leukemia/small lymphocytic lymphoma (6.9%), and T-lymphoblastic leukemia/lymphoma (6.1%). Among the 2,943 extranodal lymphomas, diffuse large B-cell lymphoma was the most common (1,117 patients, 38.0%), followed by extranodal NK/T-cell lymphoma, nasal type (498 patients, 16.9%), extranodal marginal zone B-cell lymphoma (340 patients, 11.6%), and plasmacytic neoplasm (227 patients, 7.7%) ❚Table 4❚. For the 720 gastrointestinal sites, diffuse large B-cell lymphoma was the most common (379 patients, 52.6%), followed by extranodal marginal zone B-cell lymphoma (196 patients, 27.2%) and extranodal NK/T-cell lymphoma, nasal type (31 patients, 4.3%). For the 385 nasal cavity/sinus sites, extranodal NK/T-cell lymphoma, nasal type, was the most common (286 patients, 74.3%), followed by diffuse large B-cell lymphoma (48 patients, 12.5%) and peripheral T-cell lymphoma, NOS (16 patients, 3.1%).
Among the 399 patients with Hodgkin lymphoma, most cases (338 patients, 84.7%) were diagnosed by examination of lymph nodes; 32 cases (8.0%) were found in the mediastinum.
Discussion
The distribution of lymphoid neoplasms shows marked variation in different parts of the world, reflecting etiologic heterogeneity and the participation of both genetic and environmental factors in lymphomagenesis. To estimate the distribution of lymphoid neoplasms in China and the differences between China and other countries, we conducted a comprehensive analysis, based on the subtype, age, sex, and lesion, of primary and resected biopsy specimens of 4,638 lymphoid neoplasms. Our findings are in agreement with previous results showing relatively higher proportions of patients with T/NK-cell neoplasms and relatively lower proportions of patients with follicular lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Chinese individuals compared with Western populations. 13, 15, 16 Mature B-cell neoplasms comprise more than 90% of lymphoid neoplasms in Western countries. 6 The most common types are follicular lymphoma and diffuse large B-cell lymphoma. However, mature B-cell neoplasms only accounted for 64.3% of all lymphoid neoplasms in our study, which was much lower than in Western countries. Diffuse large B-cell lymphoma is the most prevalent histologic subtype of lymphoid neoplasms worldwide. 5, 6 The proportion of diffuse large B-cell lymphoma in our study is similar to that reported in the literature for Asian and Western populations. [14] [15] [16] [17] 22, 23 In our study, follicular lymphoma accounted for 2.9% of all lymphoid neoplasms. This proportion is similar to that seen in Korean data 17 but much lower than in Japanese data. 14 Japan studies have found a relatively high rate of follicular lymphoma (19%), 14 which is similar to that of Western countries (11%-30%). 10 For extranodal marginal zone B-cell lymphoma, the frequency observed in this study is similar to that of previous Korean data 17 and higher than the Japanese or US data. 14, 16 The high proportion of extranodal marginal zone B-cell lymphoma is likely because of the high prevalence of Helicobacter pylori infections in China. 24 Chronic lymphocytic leukemia is the most common leukemia of adults in Western countries. 6 In the United States, chronic lymphocytic leukemia/small lymphocytic lymphoma accounts for 14.8% of all lymphoid neoplasms, 14 whereas previous results have shown that it is very rare in far-eastern countries. In the current study, chronic lymphocytic leukemia/ small lymphocytic lymphoma accounted for only 3.7% of all lymphoid neoplasms; this result is similar to that seen in studies from Japan and Korea. 14, 17 The low incidence in East Asians is maintained in migrant populations in the United States. 25 These observations strongly suggest that host-related genetic factors play an important role in the pathogenesis of this disease. However, all cases in this study were diagnosed based on tissue samples. Some cases of chronic lymphocytic leukemia/small lymphocytic lymphoma might be diagnosed based only on blood samples, making the number of chronic lymphocytic leukemia/small lymphocytic lymphoma small.
T/NK-cell neoplasms show significant variations in incidence in different geographical regions and racial populations. In our study, mature T/NK-cell neoplasms accounted for 23.3% of all lymphoid neoplasms. This result is similar to that of other Asian countries, including Japan, 14 Thailand, 26 Korea, 17 and India, 27 but much higher than the rates in Western countries. 15, 16 The most common types were extranodal NK/T-cell lymphoma, nasal type, which made up almost half of all mature T/NK-cell neoplasms in our study.
Extranodal NK/T-cell lymphoma is more prevalent in Asia and is closely related to Epstein Barr virus (EBV) infection. 28 In Hong Kong, extranodal NK/T-cell lymphoma is one of the more common subtypes, accounting for 8% of cases. 28 By contrast, in Europe and North America, it accounts for fewer than 1% of all lymphoid neoplasms. In our study, extranodal NK/T-cell lymphoma, nasal type, accounted for 11.0% of all lymphoid neoplasms, which is close to the rate in Korea 17 and Hong Kong. 28 These results suggest that genetic susceptibility could therefore reflect an inherited or acquired impaired immunity against EBV.
Most mature non-Hodgkin lymphomas in our study were diseases of adults (mean age, 51.6 years), whereas precursor lymphoid neoplasms were found in young individuals (mean age, 24.7 years). The mean age of mature non-Hodgkin lymphomas in our study is much lower than that of Western countries. 15 This characteristic is likely because of the higher proportions of mature T/NK-cell lymphomas in China, which tends to be diagnosed at younger ages.
In agreement with previous studies, 14, 16, 17, 29, 30 most subtypes of lymphoid neoplasms in our study showed a male predominance, with an average M/F ratio of 1.7. Among B-cell neoplasms, roughly equal numbers of male and female patients were diagnosed with follicular lymphoma and with extranodal marginal zone B-cell lymphoma, but the sex ratio for most other B-cell lymphomas showed a male predominance (Burkitt lymphoma, 5.7; mantle cell lymphomas, 2.5; plasmacytic neoplasm, 2.5; chronic lymphocytic leukemia/small lymphocytic lymphoma, 2.3). Among T/NKcell neoplasms and Hodgkin lymphoma, male predominance was seen for extranodal NK/T-cell lymphoma, nasal type (2.6), mixed cellularity Hodgkin lymphoma (2.5), and T-lymphoblastic leukemia/lymphoma (2.4).
Compared with Western countries and Japan, 14,31,32 our study found a higher rate of extranodal lymphoma. Extranodal lymphomas were found in 2,943 (63.5%) of the 4,638 patients in our study. Of these patients, approximately one quarter had gastrointestinal tract involvement. These findings are consistent with a previous study from China 33 in which the incidence of extranodal lymphomas was 61.4% of all non-Hodgkin lymphoma, and gastrointestinal tract involvement accounted for 34.8% of the extranodal lymphoma cases. The high rate of gastrointestinal tract involvement is likely because of the high prevalence of H pylori infections in China.
In summary, our study showed that the epidemiologic features of lymphoid neoplasms in China are distinct from those seen in Western countries but are similar to those seen in the Far East. These results strongly suggest an etiologic heterogeneity among lymphoid neoplasms and participation of both genetic and environmental factors, thus supporting the pursuit of epidemiologic analysis by subtype.
